Navigation Links
Intralink-Spine Inc. Awarded $750,000 Small Business Innovation Research Phase II Grant
Date:2/1/2010

GEORGETOWN, Texas, Feb. 1 /PRNewswire/ -- Intralink-Spine Inc. (ILS), a privately held medical device company focused on the treatment of degenerative disc disease and low back pain, announced today that it has been awarded a $750,000 Small Business Innovation Research (SBIR) Grant from the National Institutes of Health (NIH) for pre-clinical studies of its NEXT technology.  

Dr. Thomas Hedman, Ph.D., Founder and CSO of ILS, commented: "Securing this grant enables us to complete pre-clinical testing and start First-in-Man clinical trials.  This grant also underscores the mounting enthusiasm for our unique injectable treatment for low back pain, which affects over 15 million people each year in the US alone."

The technology, NEXT (Nonsurgical EXogenous crosslink Therapy), is based on the body's natural response to heal instability and degradation of the spinal disc.  The NEXT device is designed to immediately strengthen and stabilize the disc, reducing disc bulge and pain without the costs and risks associated with surgery.  Dr. Hansen Yuan, M.D., a leader in spine surgery, added: "This injectable tissue reinforcement procedure can provide an effective treatment for patients who are either early in the disease process or adverse to surgery."

About Intralink-Spine Inc.

Intralink-Spine Inc. (ILS) is privately held by Orthopeutics LP (OLP, Georgetown, TX) and a group of angel investors.  OLP is a biotechnology innovator founded in September of 2004 to develop and commercialize revolutionary non-surgical solutions for common orthopaedic problems.  OLP's general partner is Ampac Biotechnology, Inc. also located in Georgetown, TX.  Ampac was founded in 2001 when it was awarded an STTR Phase I grant from the NIH.

For more information on ILS, please visit: www.intralink-spine.com.

Forward-looking statements

This news release contains forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of risks and uncertainties impacting ILS's business including increased competition; the ability of ILS to expand its operations and to attract and retain qualified professionals; technological obsolescence; general economic conditions; and other risks.

SOURCE Intralink-Spine Inc.

RELATED LINKS
http://www.intralink-spine.com

'/>"/>

SOURCE Intralink-Spine Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Palmer Labs Awarded U.S. Department of Energy Funding for Algae Biofuel Research
2. Prometheus Research Awarded National Science Foundation Grant for Easy to Use, Web-Enabled Database Software
3. Goble & Associates Creative Work Awarded at Advertising Industry Competitions
4. Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project
5. Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases
6. Blue Marble Energy, OPDA Awarded $2M by WAs Community Economic Revitalization Board
7. Daval International Awarded Orphan Drug Designation for Motor Neurone Disease Treatment
8. Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus
9. BioNanomatrix Awarded Supplemental Funding to Accelerate Commercialization of Innovative Single-Molecule Analyzer
10. Novavax Awarded NIH Grant for Respiratory Syncytial Virus (RSV) Vaccine Program
11. Medicago awarded contract by the U.S. Army to explore applications of its plant-based technology in renewable energy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 2017 , ... A new study published in Fertility and ... in vitro fertilization (IVF) transfer cycles. The multi-center matched cohort study ... comparing the results from the fresh and frozen transfer cohorts, the authors of ...
(Date:10/10/2017)... CA (PRWEB) , ... October ... ... a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today ... of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration ...
(Date:10/10/2017)... International research firm Parks Associates announced today that ... TMA 2017 Annual Meeting , October 11 in Scottsdale, ... security market and how smart safety and security products impact the competitive ... Parks Associates: Smart Home Devices: Main ... "The residential security market has experienced continued ...
(Date:10/10/2017)... ... 2017 , ... The Pittcon Program Committee is pleased to ... who have made outstanding contributions to analytical chemistry and applied spectroscopy. Each award ... conference and exposition for laboratory science, which will be held February 26-March 1, ...
Breaking Biology Technology:
(Date:6/23/2017)... ITHACA, N.Y. , June 23, 2017 /PRNewswire/ ... leader in dairy research, today announced a new collaboration ... reduce the chances that the global milk supply is ... dairy project, Cornell University has become the newest academic ... Supply Chain, a food safety initiative that includes IBM ...
(Date:5/16/2017)... 16, 2017   Bridge Patient Portal , ... MD EMR Systems , an electronic medical ... GE, have established a partnership to build an ... the GE Centricity™ products, including Centricity Practice Solution ... These new integrations will allow healthcare delivery ...
(Date:4/18/2017)... a global expert in SoC-based imaging and computing solutions, has developed ... the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® , ... showcased during the upcoming Medtec Japan at Tokyo Big Sight April ... Vegas Convention Center April 24-27. ... Click here for an image of the M820 ...
Breaking Biology News(10 mins):